BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37774952)

  • 1. Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay.
    Zhang S; Jiang C; Jiang L; Chen H; Huang J; Gao X; Xia Z; Tran LJ; Zhang J; Chi H; Yang G; Tian G
    Tumour Virus Res; 2023 Dec; 16():200271. PubMed ID: 37774952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the immune microenvironment and molecular subtypes of hepatitis B-related liver cirrhosis and developing stable a diagnostic differential model by machine learning and artificial neural networks.
    Zhang S; Jiang C; Jiang L; Chen H; Huang J; Zhang J; Wang R; Chi H; Yang G; Tian G
    Front Mol Biosci; 2023; 10():1275897. PubMed ID: 37808522
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction and validation of a joint diagnosis model based on random forest and artificial intelligence network for hepatitis B-related hepatocellular carcinoma.
    Jiang X; Hu J; Xie S
    Transl Cancer Res; 2024 Feb; 13(2):1068-1082. PubMed ID: 38482416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.
    Nong S; Chen X; Wang Z; Xu G; Wei W; Peng B; Zhou L; Wei L; Zhao J; Wei Q; Deng Y; Meng L
    Biomed Res Int; 2021; 2021():9972011. PubMed ID: 34692847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
    Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM
    World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
    Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
    Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
    Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
    Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
    Yan SY; Fan JG; Qio L
    Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning.
    Chen S; Zhang Z; Wang Y; Fang M; Zhou J; Li Y; Dai E; Feng Z; Wang H; Yang Z; Li Y; Huang X; Jia J; Li S; Huang C; Tong L; Xiao X; He Y; Duan Y; Zhu S; Gao C
    J Infect Dis; 2021 Jun; 223(11):1887-1896. PubMed ID: 33049037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.
    Xing T; Li L; Rao X; Zhao J; Chen Y; Ju G; Xu Y; Gao X; Dong G; Xia X; Guan Y; Zhang L; Wen Z; Liang J
    BMC Gastroenterol; 2024 Jan; 24(1):11. PubMed ID: 38166741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occult hepatitis B virus infection and hepatocellular carcinoma].
    Lee JJ; Kwon OS
    Korean J Gastroenterol; 2013 Sep; 62(3):160-4. PubMed ID: 24077626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus-related hepatocellular carcinoma presenting at an advanced stage: is it preventable?
    Mules T; Gane E; Lithgow O; Bartlett A; McCall J
    N Z Med J; 2018 Nov; 131(1486):27-35. PubMed ID: 30496164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA.
    Lin D; Luo R; Ye Z; Wei Q; Bae H; Juon HS; Hann HW; Posey J; Wang C
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102161. PubMed ID: 37307947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis.
    Li S; Liu D; Wang Q
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
    Zhang MH; Yuan YF; Liu LJ; Wei YX; Yin WY; Zheng LZ; Tang YY; Lv Z; Zhu F
    World J Gastroenterol; 2023 Aug; 29(31):4706-4735. PubMed ID: 37664153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
    Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.